Concerns are mounting over the phenomenon of "tech neck" among young smartphone users, prompting spine experts to call for ...

Kenvue stock has recently seen its consensus analyst price target decrease modestly from $21.70 to $20.63. This slight adjustment reflects a mix of new insights, as analysts weigh fresh legal and ...

Albert Invent announced in early 2025 a multi-year partnership with Kenvue Inc. to integrate advanced AI models into Kenvue’s global R&D processes, aiming to streamline and accelerate product ...

A pair of new studies published Wednesday in the journal Neurology Open Access linked gum disease and cavities to a higher ...

“For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly concluded that the data do not support a causal association between acetaminophen ...